SCHEMBL2594604

SCHEMBL2594604

Oc1ccc(Cl)c(-c2ccc3nc(Nc4ccc(OCCn5[c]ccc5)cc4)ncc3c2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 7/20 0.48
▸ BRAF P15056 5/20 0.47
▸ RIPK2 O43353 4/20 0.46
▸ PDGFRB P09619 3/20 0.46
▸ YES1 P07947 2/20 0.46
▸ CIT O14578 1/20 0.46
▸ GAK O14976 1/20 0.46
▸ EPHB6 O15197 1/20 0.46
▸ PRKD3 O94806 1/20 0.46
▸ ABL1 P00519 1/20 0.46
▸ LCK P06239 1/20 0.46
▸ RET P07949 1/20 0.46
▸ BCR P11274 1/20 0.46
▸ EPHA2 P29317 1/20 0.46
▸ EPHB2 P29323 1/20 0.46
▸ TYK2 P29597 1/20 0.46
▸ KDR P35968 1/20 0.46
▸ ACVR1B P36896 1/20 0.46
▸ TGFBR1 P36897 1/20 0.46
▸ ABL2 P42684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL229860 0.84 BRAF (0.68) SRCBRAFRIPK2PDGFRBYES1
SCHEMBL226245 0.83 SRC (0.67) SRCBRAFRIPK2PDGFRBYES1
SCHEMBL2580765 0.75 SRC (0.46) SRCBRAFRIPK2PDGFRBYES1
SCHEMBL42236 0.74 SRC (0.57) SRCBRAFPDGFRBABL1LCK
SCHEMBL41314 0.73 BRAF (0.42) SRCBRAFPDGFRBABL1FGFR1
SCHEMBL41349 0.72 SRC (0.62) SRCBRAFPDGFRBFGFR1
SCHEMBL229386 0.72 BRAF (0.43) SRCBRAFRIPK2PDGFRBYES1
SCHEMBL229387 0.72 BRAF (0.43) SRCBRAFRIPK2PDGFRBYES1
SCHEMBL40934 0.72 SYK (0.47) SRCBRAFABL1KDR
SCHEMBL2576460 0.71 BRAF (0.41) SRCBRAFRIPK2PDGFRBYES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2381943-A1 SUBSTITUTED QUINAZOLINE COMPOUNDS Fovea Pharmaceuticals (FR) 2011-11-02 — — EP disclosed
WO-2010076238-A1 SUBSTITUTED QUINAZOLINE COMPOUNDS FOVEA PHARMACEUTICALS SA (FR) 2010-07-08 — — WO disclosed
Send feedback